1. DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro
- Author
-
Ramona Nudischer, Hans Gmuender, Ralf Herwig, Nathalie Selevsek, Olivia Clayton, Jos C. S. Kleinjans, Marcha Verheijen, Matthias Lienhard, Florian Caiment, Joep P.M. Geraedts, Stefano Gotta, Yannick Schrooders, Ralph Schlapbach, Bernd Timmermann, Stefan Boerno, Toxicogenomics, RS: GROW - R1 - Prevention, University of Zurich, and Caiment, F
- Subjects
Epigenomics ,Male ,0301 basic medicine ,lcsh:Medicine ,Cryopreservation ,ASSISTED REPRODUCTIVE TECHNOLOGIES ,Epigenesis, Genetic ,Transcriptome ,Cryoprotective Agents ,0302 clinical medicine ,Myocytes, Cardiac ,lcsh:Science ,Biological Phenomena ,Multidisciplinary ,Chemistry ,DIMETHYL-SULFOXIDE ,In vitro toxicology ,Methylation ,READ ALIGNMENT ,3. Good health ,Cell biology ,DNA methylation ,BOVINE ,Female ,HEALTH ,Primary Cell Culture ,Embryonic Development ,610 Medicine & health ,10071 Functional Genomics Center Zurich ,MATURATION ,Article ,03 medical and health sciences ,microRNA ,Humans ,Dimethyl Sulfoxide ,Epigenetics ,PRENATAL EXPOSURE ,FROZEN EMBRYOS ,1000 Multidisciplinary ,EMBRYO DEVELOPMENT ,Gene Expression Profiling ,lcsh:R ,DNA Methylation ,MicroRNAs ,030104 developmental biology ,Hepatocytes ,Oocytes ,Solvents ,570 Life sciences ,biology ,lcsh:Q ,CHILDREN BORN ,030217 neurology & neurosurgery - Abstract
Though clinical trials for medical applications of dimethyl sulfoxide (DMSO) reported toxicity in the 1960s, later, the FDA classified DMSO in the safest solvent category. DMSO became widely used in many biomedical fields and biological effects were overlooked. Meanwhile, biomedical science has evolved towards sensitive high-throughput techniques and new research areas, including epigenomics and microRNAs. Considering its wide use, especially for cryopreservation and in vitro assays, we evaluated biological effect of DMSO using these technological innovations. We exposed 3D cardiac and hepatic microtissues to medium with or without 0.1% DMSO and analyzed the transcriptome, proteome and DNA methylation profiles. In both tissue types, transcriptome analysis detected >2000 differentially expressed genes affecting similar biological processes, thereby indicating consistent cross-organ actions of DMSO. Furthermore, microRNA analysis revealed large-scale deregulations of cardiac microRNAs and smaller, though still massive, effects in hepatic microtissues. Genome-wide methylation patterns also revealed tissue-specificity. While hepatic microtissues demonstrated non-significant changes, findings from cardiac microtissues suggested disruption of DNA methylation mechanisms leading to genome-wide changes. The extreme changes in microRNAs and alterations in the epigenetic landscape indicate that DMSO is not inert. Its use should be reconsidered, especially for cryopreservation of embryos and oocytes, since it may impact embryonic development.
- Published
- 2019
- Full Text
- View/download PDF